13F filing recap · Q1 2017

What did Matrix Asset Advisors buy in Q1 2017?

Reported stock-position changes between this filing and the previous one.

Stock value

$569.26M

Positions

Estimated turnover

12.7%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

CLColgate-Palmolive Company$203.0Kreported value+2.8K shares

Increased positions

CVSCVS Health Corp$19.80Mreported value+78.7K shares+45.3%PEPPepsico, Inc.$16.40Mreported value+11.2K shares+8.3%GILDGilead Sciences, Inc.$14.58Mreported value+16.6K shares+8.4%OXYOccidental Petroleum Corporation$13.49Mreported value+17.1K shares

Reduced positions

JPMJPMorgan Chase & Co$27.67Mreported value-30.4K shares-8.8%WFCWells Fargo & Company/mn$26.19Mreported value-19.0K shares-3.9%MSFTMicrosoft Corporation$23.46Mreported value-18.0K shares-4.8%ETNEaton Corporation Plc$23.06Mreported value-10.2K shares

Exited positions

TEVATeva Pharmaceutical Industries Limited$9.46Mprior reported value-261.0K shares-100.0%SCHWSchwab Charles Corp$7.37Mprior reported value-186.6K shares-100.0%TWXTime Warner Inc$804.0Kprior reported value-8.3K shares-100.0%UNHUnitedHealth Group Incorporated$647.0Kprior reported value